MedPath

Treatment With Radiofrequency in Patients With Chronic Pelvic Pain and History of Endometriosis

Not Applicable
Conditions
Endometriosis
Chronic Pain
Quality of Life
Interventions
Device: Radiofrequency B
Device: Radiofrequency A
Registration Number
NCT04012034
Lead Sponsor
Hospital Clinic of Barcelona
Brief Summary

Managing chronic pelvic pain in patients with a past history of endometriosis might be a challenge for the gynaecologist.

The objective of this study is to evaluate pelvic pain after treatment with radiofrequency in patients with chronic pelvic pain and surgery for endometriosis.

Detailed Description

Patients with pelvic chronic pain and a past history of endometriosis without imaging evidence of endometriosis in the present will be enrolled in this study. The main objective of this study is to evaluate improvement of pelvic pain these patients. Moreover, quality of life and sexual function will be also assessed. Patients who are enrolled will come once a week per eight weeks to the hospital to have 30 minutes treatment with radiofrequency. They will be randomised in two groups, one receiving the radiofrequency and the other not (the device will be not give the energy). At the enrollement visit, the SF-36, VAS score, anxiety and depression tests and sexual function tests will be answered the patients. At the end of the treatment, and one month after the end, they will answer the same questionnaires.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
26
Inclusion Criteria
  • Chronic pelvic pain
  • Past surgery for endometriosis
Exclusion Criteria
  • Active endometriosis, diagnosed by imaging techniques
  • Presence of other diseases that can cause chronic pelvic pain
  • Contraindication for the radiofrequency use: pregnancy, metallic prothesis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboRadiofrequency BTreatment with radiofrequency without energy
Radiofrequency ARadiofrequency ATreatment with radiofrequency
Primary Outcome Measures
NameTimeMethod
Pain: VAS score1 month after study completion

Visual Analogue Scale Score, from 0 to 10, where 0 is no pain at all and 10 is the worst pain ever.

Secondary Outcome Measures
NameTimeMethod
Female Sexual Function Index (FSFI)1 month after study completion

Female Sexual Function Index (FSFI), minimum score is 2 and maximum score is 36, meaning no disfunction at all

Quality of life: QoL SF-361 month after study completion

QoL SF-36, scale where 0 is maximum disability and a score of 100 is equivalent to no disability

Trial Locations

Locations (1)

Hospital Clinic

🇪🇸

Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath